Exotics

Clinical trials for exotics

  • Status:  Currently enrolling

    Description

    The investigators hypothesize that it is possible to establish squamous cell carcinoma (SCC) cell  lines from tumors originating from non-domestic species. The objective of this study is to establish primary cell lines for avian SCC. The investigators predict that establishment of these cell lines is an important step to better identifying viable treatment options for this tumor in birds.

    Inclusion Criteria

    Birds diagnosed with squamous cell carcinoma.

    Exclusion Criteria

    Birds that have not been diagnosed with squamous cell carcinoma.

    Client Benefits
    Clients will receive a discount on services if they participate in this study.

    Contact Information

    Jennifer Graham, DVM, Dipl. ABVP (Avian / Exotic Companion Mammal), Dipl. ACZM

    508-887-4745

     

     

  • Status:  Currently enrolling

    Description:

    Our aims are to determine if removal of the ovaries or entire reproductive tract after removal of fibroadenomas (tumor) in rats will prevent or delay development of a new fibroadenoma at the same or at a distant location.

    With mammary tumors being the most common reason pet rats present to clinical practice, this project has the potential to impact all rat owners and their pet rats. This project may also be useful to the laboratory animal community since ovariectomy or ovariohystectomy at the time of fibroadenoma removal and impact on recurrence of fibroadenomas has not been investigated in laboratory rats.

    Inclusion criteria:

    Rats will be 6 months to 2.5 years old and weigh 150 grams to 350 grams

    Rats will be intact females presenting with masses suspected to be mammary fibroadenoma.

    Rats should otherwise be assessed as healthy and able to undergo routine surgery.

    Client Benefits:

    All rats will receive histologic examination (under the microscope) of their tumors at no charge once the study is funded.

    Any surgical procedures (including spay, ovariectomy, and mass removals) are charged under an established package price that includes anesthesia, surgery, and hospitalization.

    Your pet’s participation will also allow us to gain information that will help in the treatment of other rats with this condition. You understand that your animal’s participation in this study may not alleviate or cure his/her ailment.

    Contact information:

    For questions regarding the clinical trial please email the clinical trials technician, Diane Welsh at: clinicaltrials@tufts.edu

  • CSRC Protocol # 111.16

    Status:  Currently enrolling

    Description

    The purpose of the study is to determine whether ultrasound can be used to determine normal gastrointestinal (GI) motility in rabbits. With the information obtained from this study, we hope to better evaluate and treat rabbits with GI disease (also known as 'GI stasis' or 'ileus').

    Inclusion Criteria:

    Non-sedated group: 10 healthy client-owned rabbits of randomly selected breed, sex, and size

    Sedated group:  10 healthy (randomly selected breed, sex, and size) rabbits presenting for routine ovariohysterectomy or castration before and after sedation for surgery

    Client Benefits:

    The study will cover the cost of the ultrasound and sedation that would be used in the rabbits undergoing routine spay and neuter. Your pet's participation will also allow us to gain information which will help in the diagnosis/management/treatment of rabbits with GI disease. You understand that your animal's participation in this study may not alleviate or cure his/her ailment

    Contact information:

    For questions regarding the clinical trial please email the clinical trials technician, Diane Welsh at: clinicaltrials@tufts.edu

     

     

  • IACUC Protocol # G2016-161

    Status: Currently enrolling

    Description:

    To develop tests to measure lymphocyte function in healthy animals, which will then be able to be used to monitor disease in sick dogs and rabbits. Lymphocytes are a type of white blood cells that function as part of the immune system. Normally, they respond properly to foreign invaders in the body. When the lymphocytes do not act properly diseases may occur.

    Once adequately developed and validated, the proposed tests will allow us to evaluate immune function in dogs and rabbits with diseases affecting their immune systems. The various applications of these tests include evaluating rabbits with Encephalitozoon cuniculi, an infection also affecting humans, and measuring the effects of immune suppressing drugs taken by both dogs and humans.  To be able to measure immune responses in sick patients, we must first develop the tests in blood from healthy animals.

    Inclusion Criteria:

    Healthy dogs weighing more than 5 kg and between the ages of 1 and 12

    Healthy rabbits weighing more than 1 kg and between the ages of 1 and 6

    Exclusion criteria:

    Dogs: weighing < 5 kg

    < 1 year old or > 12 years old

    Pregnant

    Rabbits: weighing < 1 kg

    < 1 year old or > 6 years old

    Pregnant

    Contact information:

    For questions regarding the clinical trial please email the clinical trials technician, Diane Welsh at:  clinicaltrials@tufts.edu